BUB1 mediation of caspase-independent mitotic death determines cell fate

Journal of Cell Biology

Volumn 178, Issue 2, 2007, Pages 283-296

  Niikura, Yohei ^a   Dixit, Amruta ^b   Scott, Ray ^b   Perkins, Guy ^b   Kitagawa, Katsumi ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINOGELDANAMYCIN; APOPTOSIS INDUCING FACTOR; BUB1 RELATED PROTEIN; CASPASE; CASPASE INDEPENDENT MITOTIC DEATH; DNA FRAGMENT; ENDONUCLEASE G; GENE PRODUCT; HEAT SHOCK PROTEIN 90 INHIBITOR; NOCODAZOLE; PACLITAXEL; PROTEIN P53; PROTEIN P73; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CELL CULTURE; CELL DEATH; CELL FATE; CHROMOSOMAL INSTABILITY; COLON TUMOR; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MITOSIS; PRIORITY JOURNAL; SPINDLE CELL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS INDUCING FACTOR; BENZOQUINONES; CACO-2 CELLS; CASPASES; CELL LINE, TUMOR; CHROMOSOMES; COLD; DNA FRAGMENTATION; DNA-BINDING PROTEINS; ENDODEOXYRIBONUCLEASES; ENZYME ACTIVATION; GENOMIC INSTABILITY; HCT116 CELLS; HELA CELLS; HUMANS; LACTAMS, MACROCYCLIC; MITOSIS; MODELS, BIOLOGICAL; NOCODAZOLE; NUCLEAR PROTEINS; PACLITAXEL; PROTEIN KINASES; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEINS;

EID: 34447529458     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200702134     Document Type: Article

References (89)

1. Asnaghi, L., A. Calastretti, A. Bevilacqua, I. D'Agnano, G. Gatti, G. Canti, D. Delia, S. Capaccioli, and A. Nicolin. 2004. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. Oncogene. 23:5781-5791.
2. Babu, J.R., K.B. Jeganathan, D.J. Baker, X. Wu, N. Kang-Decker, and J.M. van Deursen. 2003. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160:341-353.
3. Banerji, U., A. O'Donnell, M. Scurr, S. Pacey, S. Stapleton, Y. Asad, L. Simmons, A. Maloney, F. Raynaud, M. Campbell, et al. 2005. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17- demethoxygeldanamycin in patients with advanced malignancies. J. Clin. Oncol. 23:4152-4161.
4. Barni, S., L. Sciola, A. Spano, and P. Pippia. 1996. Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. Biotech. Histochem. 71:66-70.
5. Barsoum, M.J., H. Yuan, A.A. Gerencser, G. Liot, Y. Kushnareva, S. Graber, I. Kovacs, W.D. Lee, J. Waggoner, J. Cui, et al. 2006. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 25:3900-3911.
6. Basu, J., H. Bousbaa, E. Logarinho, Z. Li, B.C. Williams, C. Lopes, C.E. Sunkel, and M.L. Goldberg. 1999. Mutations in the essential spindle checkpoint gene bub1 cause chromosome missegregation and fail to block apoptosis in Drosophila. J. Cell Biol. 146:13-28.
7. Bidere, N., H.K. Lorenzo, S. Carmona, M. Laforge, F. Harper, C. Dumont, and A. Senik. 2003. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278:31401-31411.
8. Blank, M., Y. Lerenthal, L. Mittelman, and Y. Shiloh. 2006. Condensin I recruitment and uneven chromatin condensation precede mitotic cell death in response to DNA damage. J. Cell Biol. 174:195-206.
9. Blasco, M.A., H.W. Lee, M.P. Hande, E. Samper, P.M. Lansdorp, R.A. DePinho, and C.W. Greider. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:25-34.
10. Burns, T.F., P. Fei, K.A. Scata, D.T. Dicker, and W.S. El-Deiry. 2003. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol. Cell. Biol. 23:5556-5571.
11. Cahill, D.P., C. Lengauer, J. Yu, G.J. Riggins, J.K. Willson, S.D. Markowitz, K.W. Kinzler, and B. Vogelstein. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:300-303.
12. Carvalho, A., M. Carmena, C. Sambade, W.C. Earnshaw, and S.P. Wheatley. 2003. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 116:2987-2998.
13. Castedo, M., J.L. Perfettini, T. Roumier, K. Andreau, R. Medema, and G. Kroemer. 2004. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 23:2825-2837.
14. Chipuk, J.E., and D.R. Green. 2005. Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 6:268-275.
15. Coates, P. 2006. Regulating p73 isoforms in human tumours. J. Pathol. 210:385-389.
16. Cowley, D.O., G.W. Muse, and T. Van Dyke. 2005. A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background. Mol. Cell. Biol. 25:7796-7802.
17. Cregan, S.P., A. Fortin, J.G. MacLaurin, S.M. Callaghan, F. Cecconi, S.W. Yu, T.M. Dawson, V.L. Dawson, D.S. Park, G. Kroemer, and R.S. Slack. 2002. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 158:507-517.
18. Cregan, S.P., V.L. Dawson, and R.S. Slack. 2004. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene. 23:2785-2796.
19. Dai, W., Q. Wang, T. Liu, M. Swamy, Y. Fang, S. Xie, R. Mahmood, Y.M. Yang, M. Xu, and C.V. Rao. 2004. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res. 64:440-445.
20. David, K.K., M. Sasaki, S.W. Yu, T.M. Dawson, and V.L. Dawson. 2006. EndoG is dispensable in embryogenesis and apoptosis. Cell Death Differ. 13:1147-1155.
21. DeLuca, J.G., B. Moree, J.M. Hickey, J.V. Kilmartin, and E.D. Salmon. 2002. hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells. J. Cell Biol. 159:549-555.
22. Dobles, M., V. Liberal, M.L. Scott, R. Benezra, and P.K. Sorger. 2000. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell. 101:635-645.
23. Elbashir, S.M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494-498.
24. Eskelinen, E.L. 2005. Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death. Cell Death Differ. 12(Suppl 2): 1468-1472.
25. Fortugno, P., E. Beltrami, J. Plescia, J. Fontana, D. Pradhan, P.C. Marchisio, W.C. Sessa, and D.C. Altieri. 2003. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. USA. 100:13791-13796.
26. Fulco, M., A. Costanzo, P. Merlo, R. Mangiacasale, S. Strano, G. Blandino, C. Balsano, P. Lavia, and M. Levrero. 2003. p73 is regulated by phosphorylation at the G2/M transition. J. Biol. Chem. 278:49196-49202.
27. Glaze, E.R., A.L. Lambert, A.C. Smith, J.G. Page, W.D. Johnson, D.L. McCormick, A.P. Brown, B.S. Levine, J.M. Covey, M.J. Egorin, et al. 2005. Preclinical toxicity of a geldanamycin analog, 17-(dimethyl aminoethylamino)-17- demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance. Cancer Chemother Pharmacol. 56:637-647.
28. Goetz, M.P., D. Toft, J. Reid, M. Ames, B. Stensgard, S. Safgren, A.A. Adjei, J. Sloan, P. Atherton, V. Vasile, et al. 2005. Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J. Clin. Oncol. 23:1078-1087.
29. Grem, J.L., G. Morrison, X.D. Guo, E. Agnew, C.H. Takimoto, R. Thomas, E. Szabo, L. Grochow, F. Grollman, J.M. Hamilton, et al. 2005. Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors. J. Clin. Oncol. 23:1885-1893.
30. Hoppe-Seyler, F., and K. Butz. 1993. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol. 67:3111-3117.
31. Hoyt, M.A., L. Totis, and B.T. Roberts. 1991. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell. 66:507-517.
32. Hyland, K.M., J. Kingsbury, D. Koshland, and P. Hieter. 1999. Ctf19p: A novel kinetochore protein in Saccharomyces cerevisiae and a potential link between the kinetochore and mitotic spindle. J. Cell Biol. 145:15-28.
33. Irvine, R.A., N. Adachi, D.K. Shibata, G.D. Cassell, K. Yu, Z.E. Karanjawala, C.L. Hsieh, and M.R. Lieber. 2005. Generation and characterization of endonuclease G null mice. Mol. Cell. Biol. 25:294-302.
34. Irwin, M., M.C. Marin, A.C. Phillips, R.S. Seelan, D.I. Smith, W. Liu, E.R. Flores, K.Y. Tsai, T. Jacks, K.H. Vousden, and W.G. Kaelin Jr. 2000. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 407:645-648.
35. Johnson, V.L., M.I. Scott, S.V. Holt, D. Hussein, and S.S. Taylor. 2004. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. J. Cell Sci. 117:1577-1589.
36. Joza, N., S.A. Susin, E. Daugas, W.L. Stanford, S.K. Cho, C.Y. Li, T. Sasaki, A.J. Elia, H.Y. Cheng, L. Ravagnan, et al. 2001. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature. 410:549-554.
37. Kitagawa, K., and P. Hieter. 2001. Evolutionary conservation between budding yeast and human kinetochores. Nat. Rev. Mol. Cell Biol. 2:678-687.
38. Kitagawa, K., D. Skowyra, S.J. Elledge, J.W. Harper, and P. Hieter. 1999. SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase complex. Mol. Cell. 4:21-33.
39. Kops, G.J., D.R. Foltz, and D.W. Cleveland. 2004. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc. Natl. Acad. Sci. USA. 101:8699-8704.
40. Kops, G.J., B.A. Weaver, and D.W. Cleveland. 2005. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer. 5:773-785.
41. Kranc, K.R., S.D. Bamforth, J. Braganca, C. Norbury, M. van Lohuizen, and S. Bhattacharya. 2003. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Mol. Cell. Biol. 23:7658-7666.
42. Lamb, J.R., S. Tugendreich, and P. Hieter. 1995. Tetratrico peptide repeat interactions: to TPR or not to TPR? Trends Biochem. Sci. 20:257-259.
43. Lens, S.M., R.M. Wolthuis, R. Klompmaker, J. Kauw, R. Agami, T. Brummelkamp, G. Kops, and R.H. Medema. 2003. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 22:2934-2947.
44. Li, F., G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:580-584.
45. Li, R., and A.W. Murray. 1991. Feedback control of mitosis in budding yeast. Cell. 66:519-531.
46. Li, W., and D.W. Hoffman. 2001. Structure and dynamics of translation initiation factor aIF-1A from the archaeon Methanococcus jannaschii determined by NMR spectroscopy. Protein Sci. 10:2426-2438.
47. Martin-Lluesma, S., V.M. Stucke, and E.A. Nigg. 2002. Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science. 297:2267-2270.
48. Marusawa, H., S. Matsuzawa, K. Welsh, H. Zou, R. Armstrong, I. Tamm, and J.C. Reed. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22:2729-2740.
49. Meraldi, P., and P.K. Sorger. 2005. A dual role for Bub1 in the spindle checkpoint and chromosome congression. EMBO J. 24:1621-1633.
50. Merlo, P., M. Fulco, A. Costanzo, R. Mangiacasale, S. Strano, G. Blandino, Y. Taya, P. Lavia, and M. Levrero. 2005. A role of p73 in mitotic exit. J. Biol. Chem. 280:30354-30360.
51. Michel, L.S., V. Liberal, A. Chatterjee, R. Kirchwegger, B. Pasche, W. Gerald, M. Dobles, P.K. Sorger, V.V. Murty, and R. Benezra. 2001. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature. 409:355-359.
52. Miyata, Y. 2005. Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents. Curr. Pharm. Des. 11:1131-1138.
53. Mollinedo, F., and C. Gajate. 2003. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis. 8:413-450.
54. Niikura, Y., S. Ohta, K.J. Vandenbeldt, R. Abdulle, B.F. McEwen, and K. Kitagawa. 2006. 17-AAG, an Hsp90 inhibitor, causes kinetochore defects: a novel mechanism by which 17-AAG inhibits cell proliferation. Oncogene. 25:4133-4146.
55. Nitta, M., O. Kobayashi, S. Honda, T. Hirota, S. Kuninaka, T. Marumoto, Y. Ushio, and H. Saya. 2004. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene. 23:6548-6558
56. Ohshima, K., S. Haraoka, S. Yoshioka, M. Hamasaki, T. Fujiki, J. Suzumiya, C. Kawasaki, M. Kanda, and M. Kikuchi. 2000. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma. Cancer Lett. 158:141-150.
57. Okada, H., and T.W. Mak. 2004. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer. 4:592-603.
58. Panaretou, B., G. Siligardi, P. Meyer, A. Maloney, J.K. Sullivan, S. Singh, S.H. Millson, P.A. Clarke, S. Naaby-Hansen, R. Stein, et al. 2002. Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. Mol. Cell. 10:1307-1318.
59. Perez, G.I., B.M. Acton, A. Jurisicova, G.A. Perkins, A. White, J. Brown, A.M. Trbovich, M.-R. Kim, R. Fissore, J. Xu, et al. 2007. Genetic variance modifies apoptosis susceptibility in mature oocytes via alterations in DNA repair capacity and mitochondrial ultrastructure. Cell Death Differ. 14:524-533.
60. Perkins, G.A., M.H. Ellisman, and D.A. Fox. 2004. The structure-function correlates of mammalian rod and cone photoreceptor mitochondria: observations and unanswered questions. Mitochondrion. 4:695-703.
61. Ramadan, S., A. Terrinoni, M.V. Catani, A.E. Sayan, R.A. Knight, M. Mueller, P.H. Krammer, G. Melino, and E. Candi. 2005. p73 induces apoptosis by different mechanisms. Biochem. Biophys. Res. Commun. 331:713-717.
62. Ramanathan, R.K., D.L. Trump, J.L. Eiseman, C.P. Belani, S.S. Agarwala, E.G. Zuhowski, J. Lan, D.M. Potter, S.P. Ivy, S. Ramalingam, et al. 2005. Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17- demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers. Clin. Cancer Res. 11:3385-3391.
63. Reilly, P.T., J. Wysocka, and W. Herr. 2002. Inactivation of the retinoblastoma protein family can bypass the HCF-1 defect in tsBN67 cell proliferation and cytokinesis. Mol. Cell. Biol. 22:6767-6778.
64. Rieder, C.L., and R.W. Cole. 2002. Cold-shock and the Mammalian cell cycle. Cell Cycle. 1:169-175.
65. Rieder, C.L., and H. Maiato. 2004. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell. 7:637-651.
66. Ru, H.Y., R.L. Chen, W.C. Lu, and J.H. Chen. 2002. hBUB1 defects in leukemia and lymphoma cells. Oncogene. 21:4673-4679.
67. Saeki, A., S. Tamura, N. Ito, S. Kiso, Y. Matsuda, I. Yabuuchi, S. Kawata, and Y. Matsuzawa. 2002. Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. Cancer. 94:2047-2054.
68. Shigeishi, H., N. Oue, H. Kuniyasu, A. Wakikawa, H. Yokozaki, T. Ishikawa, and W. Yasui. 2001. Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas. Pathobiology. 69:24-29.
69. Skoufias, D.A., C. Mollinari, F.B. Lacroix, and R.L. Margolis. 2000. Human survivin is a kinetochore-associated passenger protein. J. Cell Biol. 151:1575-1582.
70. Skoufias, D.A., F.B. Lacroix, P.R. Andreassen, L. Wilson, and R.L. Margolis. 2004. Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase. Mol. Cell. 15:977-990.
71. Sonoda, Y., T. Kasahara, E. Yokota-Aizu, M. Ueno, and S. Watanabe. 1997. A suppressive role of p125FAK protein tyrosine kinase in hydrogen peroxide-induced apoptosis of T98G cells. Biochem. Biophys. Res. Commun. 241:769-774.
72. Sonoda, Y., S. Watanabe, Y. Matsumoto, E. Aizu-Yokota, and T. Kasahara. 1999. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J. Biol. Chem. 274:10566-10570.
73. Sonoda, Y., Y. Matsumoto, M. Funakoshi, D. Yamamoto, S.K. Hanks, and T. Kasahara. 2000. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275:16309-16315.
74. Sudo, T., M. Nitta, H. Saya, and N.T. Ueno. 2004. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res. 64:2502-2508.
75. Susin, S.A., H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J. Mangion, E. Jacotot, P. Costantini, M. Loeffler, et al. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441-446.
76. Susin, S.A., E. Daugas, L. Ravagnan, K. Samejima, N. Zamzami, M. Loeffler, P. Costantini, K.F. Ferri, T. Irinopoulou, M.C. Prevost, et al. 2000. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192:571-580.
77. Taylor, S.S., and F. McKeon. 1997. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell. 89:727-735.
78. Tong, A.H., M. Evangelista, A.B. Parsons, H. Xu, G.D. Bader, N. Page, M. Robinson, S. Raghibizadeh, C.W. Hogue, H. Bussey, et al. 2001. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 294:2364-2368.
79. Tsukasaki, K., C.W. Miller, E. Greenspun, S. Eshaghian, H. Kawabata, T. Fujimoto, M. Tomonaga, C. Sawyers, J.W. Said, and H.P. Koeffler. 2001. Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene. 20:3301-3305.
80. Tugendreich, S., J. Tomkiel, W. Earnshaw, and P. Hieter. 1995. CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition. Cell. 81:261-268.
81. van Loo, G., X. Saelens, F. Matthijssens, P. Schotte, R. Beyaert, W. Declercq, and P. Vandenabeele. 2002. Caspases are not localized in mitochondria during life or death. Cell Death Differ. 9:1207-1211.
82. Wang, X., D.Y. Jin, R.W. Ng, H. Feng, Y.C. Wong, A.L. Cheung, and S.W. Tsao. 2002. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62:1662-1668.
83. Wells, W.A., and A.W. Murray. 1996. Aberrantly segregating centromeres activate the spindle assembly checkpoint in budding yeast. J. Cell Biol. 133:75-84.
84. Woods, C.M., J. Zhu, P.A. McQueney, D. Bollag, and E. Lazarides. 1995. Taxolinduced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1:506-526.
85. Yang, Z., J. Guo, Q. Chen, C. Ding, J. Du, and X. Zhu. 2005. Silencing mitosin induces misaligned chromosomes, premature chromosome decondensation before anaphase onset, and mitotic cell death. Mol. Cell. Biol. 25:4062-4074.
86. Yoda, K., T. Nakamura, H. Masumoto, N. Suzuki, K. Kitagawa, M. Nakano, A. Shinjo, and T. Okazaki. 1996. Centromere protein B of African green monkey cells: gene structure, cellular expression, and centromeric localization. Mol. Cell. Biol. 16:5169-5177.
87. Yoon, D.S., R.P. Wersto, W. Zhou, F.J. Chrest, E.S. Garrett, T.K. Kwon, and E. Gabrielson. 2002. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am. J. Pathol. 161:391-397.
88. Yu, S.W., H. Wang, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, G.G. Poirier, T.M. Dawson, and V.L. Dawson. 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 297:259-263.
89. Zhang, J., M. Dong, L. Li, Y. Fan, P. Pathre, J. Dong, D. Lou, J.M. Wells, D. Olivares-Villagomez, L. Van Kaer, et al. 2003. Endonuclease G is required for early embryogenesis and normal apoptosis in mice. Proc. Natl. Acad. Sci. USA. 100:15782-15787.